BCG VACCINE (Organon USA Inc.)


Welcome to the PulseAid listing for the BCG VACCINE drug offered from Organon USA Inc.. This Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],BCG Vaccine [Chemical/Ingredient],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Organon USA Inc.
NON-PROPRIETARY NAME: BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
SUBSTANCE NAME: BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],BCG Vaccine [Chemical/Ingredient],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE]
ROUTE: PERCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1989-06-21
END MARKETING DATE: 0000-00-00


BCG VACCINE VACCINE Details:

Item DescriptionBCG VACCINE from Organon USA Inc.
LABELER NAME: Organon USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 1989-06-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0052-0603_ffcb1677-5fc1-4969-8ea6-8e12163527d3
PRODUCT NDC: 0052-0603
APPLICATION NUMBER: BLA103050

Other BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Organon USA Inc.TICE BCG